Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy

por Velayutham, Naveen Kumar, Thamaraikani, Tamilanban, Wahab, Shadma, Khalid, Mohammad, Ramachawolran, Gobinath, Abullais, Shahabe Saquib, Wong, Ling Shing, Sekar, Mahendran, Gan, Siew Hua, Ebenezer, Angel Jemima, Ravikumar, Mrinalini, Subramaniyan, Vetriselvan, Mat Rani, Nur Najihah Izzati, Wu, Yuan Seng, Jeyabalan, Srikanth
Publicado 2023

Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation

por Chehelgerdi, Mohammad, Chehelgerdi, Matin, Allela, Omer Qutaiba B., Pecho, Renzon Daniel Cosme, Jayasankar, Narayanan, Rao, Devendra Pratap, Thamaraikani, Tamilanban, Vasanthan, Manimaran, Viktor, Patrik, Lakshmaiya, Natrayan, Saadh, Mohamed J., Amajd, Ayesha, Abo-Zaid, Mabrouk A., Castillo-Acobo, Roxana Yolanda, Ismail, Ahmed H., Amin, Ali H., Akhavan-Sigari, Reza
Publicado 2023